Endocrine therapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Endocrine therapy (unspecified), covering 2024-09-25 to 2024-09-25. Get the full timeline:
Most recent: Clinical Trial Update: PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer [Phase 3]